Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000224371 | SCV000280974 | benign | not provided | 2016-01-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000244656 | SCV000304294 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000244656 | SCV000331491 | likely benign | not specified | 2016-06-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000224371 | SCV000520645 | benign | not provided | 2018-04-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23022423, 26474921, 28776642, 25888430, 26153658, 20163776, 23533021, 25333069, 22331132, 11313316, 27884173, 28176361, 28924228, 29761167, 31335238, 31538484) |
Laboratory for Molecular Medicine, |
RCV000244656 | SCV000538211 | likely benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 110/13006=8.45%; Frequency in ESP (EA): 103/8600=1.19% |
Illumina Laboratory Services, |
RCV001158467 | SCV001320109 | likely benign | Progressive familial intrahepatic cholestasis type 3 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001165181 | SCV001327354 | likely benign | Cholestasis, intrahepatic, of pregnancy, 3 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Genome- |
RCV001158467 | SCV001623468 | benign | Progressive familial intrahepatic cholestasis type 3 | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000244656 | SCV002103492 | likely benign | not specified | 2022-02-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000224371 | SCV002401089 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000224371 | SCV002545522 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | ABCB4: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV000224371 | SCV005220953 | likely benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000014690 | SCV000034945 | pathogenic | Low phospholipid associated cholelithiasis | 2001-05-01 | no assertion criteria provided | literature only |